PROPHY MED AB has a total of 26 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets pharmaceuticals, medical technology and chemical engineering are PHARMANOVA INC, ARES TRADING SA and SANGART INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Canada | 2 | |
#3 | China | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Israel | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Mexico | 2 | |
#8 | United States | 2 | |
#9 | African Regional Industrial Property Organization | 1 | |
#10 | Brazil | 1 | |
#11 | Colombia | 1 | |
#12 | Malaysia | 1 | |
#13 | Norway | 1 | |
#14 | New Zealand | 1 | |
#15 | Singapore | 1 | |
#16 | Tunisia | 1 | |
#17 | WIPO (World Intellectual Property Organization) | 1 | |
#18 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Chemical engineering | |
#4 | Environmental technology | |
#5 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Chemical or physical processes | |
#5 | Syringes | |
#6 | Peptides | |
#7 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Lyngstadaas Staale Petter | 10 |
#2 | Bruce Lars | 10 |
#3 | Nilsson Bo | 8 |
#4 | Korsgren Olle | 7 |
#5 | Olle Korsgren | 3 |
#6 | Bo Nilsson | 3 |
#7 | Petter Lyngstadaas Staale | 1 |
#8 | Bo Korsgren Olle Nilsson | 1 |
#9 | Lars Bruce | 1 |
Publication | Filing date | Title |
---|---|---|
ZA200406552B | Use of an inhibitor or antagonist against tissue factor | |
KR20050089803A | New use of dextran sulfate | |
EP1476186A1 | Use of an inhibitor or antagonist against tissue factor |